143 related articles for article (PubMed ID: 7842528)
1. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
Kiener H; Graninger W; Machold K; Aringer M; Graninger WB
Clin Exp Rheumatol; 1994; 12(5):483-7. PubMed ID: 7842528
[TBL] [Abstract][Full Text] [Related]
2. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Kadono T; Tamaki K; Takehara K
Br J Rheumatol; 1997 Dec; 36(12):1270-5. PubMed ID: 9448587
[TBL] [Abstract][Full Text] [Related]
3. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
[TBL] [Abstract][Full Text] [Related]
5. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
[TBL] [Abstract][Full Text] [Related]
8. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
Steen VD; Engel EE; Charley MR; Medsger TA
J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
[TBL] [Abstract][Full Text] [Related]
10. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
Sfikakis PP; Tesar J; Baraf H; Lipnick R; Klipple G; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):88-92. PubMed ID: 8099861
[TBL] [Abstract][Full Text] [Related]
11. Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin.
Søndergaard K; Stengaard-Pedersen K; Zachariae H; Heickendorff L; Deleuran M; Deleuran B
Br J Rheumatol; 1998 Mar; 37(3):304-10. PubMed ID: 9566672
[TBL] [Abstract][Full Text] [Related]
12. [Circulating adhesion molecules (cICAM-1, lcVCAM-1) in patients with suspected inflammatory heart muscle disease].
Klein RM; Breuer R; Mundhenke M; Schwartzkopff B; Strauer BE
Z Kardiol; 1998 Feb; 87(2):84-93. PubMed ID: 9556870
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis.
Griffiths CE; Boffa MJ; Gallatin WM; Martin S
Acta Derm Venereol; 1996 Jan; 76(1):2-5. PubMed ID: 8721479
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.
Ihn H; Fujimoto M; Sato S; Kikuchi K; Igarashi A; Soma Y; Takehara K
J Am Acad Dermatol; 1994 Oct; 31(4):591-5. PubMed ID: 7916356
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis.
Kaufmann P; Tilz GP; Smolle KH; Demel U; Krejs GJ
Immunobiology; 1996 Jul; 195(2):209-19. PubMed ID: 8877397
[TBL] [Abstract][Full Text] [Related]
16. Implication of intercellular adhesion molecule-1 (ICAM-1) and serum N(G)-hydroxy-L-arginine (L-NHA) in the pathogenesis of systemic sclerosis.
Zamzam ML; Yassin MM; Sallam MM
Egypt J Immunol; 2003; 10(2):27-38. PubMed ID: 15719609
[TBL] [Abstract][Full Text] [Related]
17. Circulating ICAM-1 is increased in septic shock.
Sessler CN; Windsor AC; Schwartz M; Watson L; Fisher BJ; Sugerman HJ; Fowler AA
Am J Respir Crit Care Med; 1995 May; 151(5):1420-7. PubMed ID: 7735595
[TBL] [Abstract][Full Text] [Related]
18. Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1.
Martin S; Rieckmann P; Melchers I; Wagner R; Bertrams J; Voskuyl AE; Roep BO; Zielasek J; Heidenthal E; Weichselbraun I
J Immunol; 1995 Feb; 154(4):1951-5. PubMed ID: 7836774
[TBL] [Abstract][Full Text] [Related]
19. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
[TBL] [Abstract][Full Text] [Related]
20. Bioactivity of prolactin in systemic sclerosis.
La Montagna G; Meli R; Criscuolo T; D'Angelo S; Valentini G
Clin Exp Rheumatol; 2004; 22(2):145-50. PubMed ID: 15083880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
